Investor Relations Home
|IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.|
The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts. We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues. It is possible that the information we post on social media channels could be deemed to be material information. We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page (www.facebook.com/IRIDEX) and Twitter feed (https://twitter.com/IRIDEX).
|11/13/13||IRIDEX To Introduce Four New Products At Annual AAO Meeting|
|Fifteen physicians, seven new to the IRIDEX podium, will discuss their experiences using MicroPulse™ for retinal and glaucoma therapies
MOUNTAIN VIEW, Calif., Nov. 13, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that it would introduce four new products at the annual meeting of the American Academy of Ophthalmology to be held November 16-19 at the Ernest N. Morial Convention Center in New Orleans. There will also be several presentations featuring IRIDEX products an... |
|11/07/13||IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales|
|MOUNTAIN VIEW, Calif., Nov. 7, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq:IRIX) today announced that, effective immediately, it has promoted sales and marketing executive Timothy D. Buckley to Vice President of Marketing and North American Sales. Buckley had previously taken over interim responsibility for domestic sales earlier this year, and will continue to report directly to James H. Mackaness, Chief Financial Officer and Chief Operating Officer.
Buckley, 38, has more than 16 years o... |
|11/06/13||IRIDEX - In The Early Innings Of Margin Expansion|
|10/31/13||IRIDEX Reports 2013 Third Quarter Results|
|RECORD REVENUE OF $9.5 MILLION IN QUARTER
MOUNTAIN VIEW, Calif., Oct. 31, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2013.
Revenues were $9.5 million in the third quarter of 2013, up 21% from $7.9 million in the prior year comparable period and up sequentially from $9.2 million in the second quarter of 2013.
Gross margin for the third quarter of 2013 was 49.6%, comparable to 49.6% in the prior year... |
|Primary IR Contact|
Chief Financial Officer and Chief Operating Officer
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.